US drug approvals
89 approvals with a product on the US market
- Varenicline Tartrate ANDA219382 · approved 6 Jul 2026
- Tofacitinib Citrate ANDA220137 · approved 3 Jun 2026
- Carboprost Tromethamine ANDA219529 · approved 27 May 2026
- Acamprosate Calcium ANDA218984 · approved 16 Mar 2026
- Rilpivirine Hydrochloride ANDA218798 · approved 29 Jan 2026
Source: Drugs@FDA, Approvals (NDA, ANDA, BLA) held, with a product sold now; newest shown. Retrieved 13 Nov 2026.